Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

479 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The EASL-Lancet Commission on liver health in Europe: prevention, case-finding, and early diagnosis to reduce liver-related mortality.
Karlsen TH, Rutter H, Carrieri P, Zelber-Sagi S, Engebretsen E, Hutchinson S, Voigt K, Guha N, Berzigotti A, Schomerus G, Gines P, Buti M, Burra P, Manns MP, Krag A, Kleinert S. Karlsen TH, et al. Among authors: gines p. Lancet. 2024 Apr 20;403(10436):1522-1524. doi: 10.1016/S0140-6736(24)00204-6. Epub 2024 Feb 12. Lancet. 2024. PMID: 38359860 Free article. No abstract available.
Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 Individuals.
Kjaergaard M, Lindvig KP, Thorhauge KH, Johansen S, Hansen JK, Andersen P, Hansen CD, Schnefeld HL, Bech KT, Torp N, Israelsen M, Detlefsen S, Graupera I, Gines P, Krag A, Thiele M. Kjaergaard M, et al. Among authors: gines p. Clin Gastroenterol Hepatol. 2024 May;22(5):1037-1047.e9. doi: 10.1016/j.cgh.2023.12.018. Epub 2023 Dec 27. Clin Gastroenterol Hepatol. 2024. PMID: 38154729 Free article.
Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study.
Ginès P, Wong F, Watson H, Terg R, Bruha R, Zarski JP, Dudley F; NormoCAT Study Investigators. Ginès P, et al. Aliment Pharmacol Ther. 2010 Apr;31(8):834-45. doi: 10.1111/j.1365-2036.2010.04236.x. Epub 2010 Jan 22. Aliment Pharmacol Ther. 2010. PMID: 20102356 Clinical Trial.
Liver Cirrhosis: ancient disease, new challenge.
Juanola A, Pose E, Ginès P. Juanola A, et al. Among authors: gines p. Med Clin (Barc). 2024 Dec 27:S0025-7753(24)00704-8. doi: 10.1016/j.medcli.2024.11.002. Online ahead of print. Med Clin (Barc). 2024. PMID: 39732564 Free article. Review. English, Spanish.
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study.
Lindvig KP, Thorhauge KH, Hansen JK, Kjærgaard M, Hansen CD, Johansen S, Lyngbeck E, Israelsen M, Andersen P, Bech KT, Torp N, Schnefeld HL, Detlefsen S, Möller S, Graupera I, Trelle MB, Antonsen S, Harris R, Kårhus LL, Bjørnsbo KS, Brøns C, Hansen T, Geier A, Wedemeyer H, Zeuzem S, Schattenberg JM, Ginès P, Guha IN, Krag A, Thiele M. Lindvig KP, et al. Among authors: gines p. Lancet Gastroenterol Hepatol. 2025 Jan;10(1):55-67. doi: 10.1016/S2468-1253(24)00274-7. Lancet Gastroenterol Hepatol. 2025. PMID: 39674225
Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis.
Lamas-Paz A, Hionides-Gutiérrez A, Guo F, Jorquera G, Morán-Blanco L, Benedé-Ubieto R, Mesquita M, Estévez-Vázquez O, Zheng K, Mazariegos M, Vázquez-Ogando E, Blázquez-López E, Asensio I, Mutlu B, Gomez-Santos B, Peligros MI, Vaquero J, Bañares R, Delgado TC, Martínez-Chantar ML, Martínez-Naves E, Sanz-García C, Mohamed MR, Tesolato S, Iniesta P, Gallego-Durán R, Maya-Miles D, Ampuero J, Romero-Gómez M, Martínez-Alcocer A, Sanfeliu-Redondo D, Fernández-Iglesias A, Gracia-Sancho J, Coll M, Graupera I, Ginès P, Ciudin A, Rivera-Esteban J, Pericàs JM, Ávila MA, Frutos MD, Martínez-Cáceres CM, Ramos-Molina B, Aspichueta P, Puigserver P, Nevzorova YA, Cubero FJ. Lamas-Paz A, et al. Among authors: gines p. JHEP Rep. 2024 Oct 5;7(1):101230. doi: 10.1016/j.jhepr.2024.101230. eCollection 2025 Jan. JHEP Rep. 2024. PMID: 39659733 Free PMC article.
Liver fibrosis screening increases alcohol abstinence.
Avitabile E, Gratacós-Ginès J, Pérez-Guasch M, Belén Rubio A, Herms Q, Cervera M, Nadal R, Carol M, Fabrellas N, Bruguera P, Llorente A, Ortega L, Lligoña A, Nuño L, Freixa N, Pons MT, Díaz A, Bataller R, Ginès P, López-Pelayo H, Pose E. Avitabile E, et al. Among authors: gines p. JHEP Rep. 2024 Jul 2;6(10):101165. doi: 10.1016/j.jhepr.2024.101165. eCollection 2024 Oct. JHEP Rep. 2024. PMID: 39380719 Free PMC article.
Population screening for cirrhosis.
Thiele M, Pose E, Juanola A, Mellinger J, Ginès P. Thiele M, et al. Among authors: gines p. Hepatol Commun. 2024 Aug 26;8(9):e0512. doi: 10.1097/HC9.0000000000000512. eCollection 2024 Sep 1. Hepatol Commun. 2024. PMID: 39185917 Free PMC article. Review.
479 results